A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy-Reference-Cited by-同舟云学术

A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy

Published:2003-06 Issue:6 Volume:37 Page:1368-1374
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Pockros P

Publisher

Wiley

Subject

Hepatology

Reference21 articles.

1. The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994

2. Alpha-glutathione transferases in HCV-related chronic hepatitis: a new predictive index of response to interferon therapy?

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

4. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferons and Interleukins;Pharmaceutical Biotechnology;2019

2. Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy;Scientific Reports;2018-06-11

3. Formal Modeling of the Key Determinants of Hepatitis C Virus (HCV) Induced Adaptive Immune Response Network: An Integrative Approach to Map the Cellular and Cytokine-Mediated Host Immune Regulations;Computational Science and Its Applications – ICCSA 2018;2018

4. Immunomodulators;Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases;2015

5. CD27 engagement by a soluble CD70 protein enhances non-cytolytic antiviral activity of CD56bright natural killer cells by IFN-γ secretion;Clinical Immunology;2013-12